Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination.
D001286:Atropine Derivatives / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D005280:Fenoterol / Q000009:adverse effects / Q000627:therapeutic use*; D005541:Forced Expiratory Volume; D006801:Humans; D009241:Ipratropium / Q000009:adverse effects / Q000627:therapeutic use*; D009330:Nebulizers and Vaporizers; D010366:Peak Expiratory Flow Rate; D012996:Solutions; D014797:Vital Capacity
D001286:Atropine Derivatives; D001993:Bronchodilator Agents; D004338:Drug Combinations; D012996:Solutions; D005280:Fenoterol; D009241:Ipratropium